8-41668396-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000037.4(ANK1):​c.5265G>A​(p.Val1755=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.234 in 1,614,112 control chromosomes in the GnomAD database, including 45,182 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4040 hom., cov: 33)
Exomes 𝑓: 0.23 ( 41142 hom. )

Consequence

ANK1
NM_000037.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.27
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 8-41668396-C-T is Benign according to our data. Variant chr8-41668396-C-T is described in ClinVar as [Benign]. Clinvar id is 261316.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-41668396-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.27 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.252 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ANK1NM_000037.4 linkuse as main transcriptc.5265G>A p.Val1755= synonymous_variant 39/43 ENST00000289734.13 NP_000028.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ANK1ENST00000289734.13 linkuse as main transcriptc.5265G>A p.Val1755= synonymous_variant 39/431 NM_000037.4 ENSP00000289734 A2P16157-3

Frequencies

GnomAD3 genomes
AF:
0.227
AC:
34461
AN:
152128
Hom.:
4030
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.199
Gnomad AMI
AF:
0.376
Gnomad AMR
AF:
0.258
Gnomad ASJ
AF:
0.292
Gnomad EAS
AF:
0.128
Gnomad SAS
AF:
0.198
Gnomad FIN
AF:
0.201
Gnomad MID
AF:
0.294
Gnomad NFE
AF:
0.243
Gnomad OTH
AF:
0.249
GnomAD3 exomes
AF:
0.217
AC:
54591
AN:
251474
Hom.:
6278
AF XY:
0.219
AC XY:
29806
AN XY:
135910
show subpopulations
Gnomad AFR exome
AF:
0.199
Gnomad AMR exome
AF:
0.195
Gnomad ASJ exome
AF:
0.290
Gnomad EAS exome
AF:
0.124
Gnomad SAS exome
AF:
0.197
Gnomad FIN exome
AF:
0.210
Gnomad NFE exome
AF:
0.241
Gnomad OTH exome
AF:
0.226
GnomAD4 exome
AF:
0.234
AC:
342714
AN:
1461866
Hom.:
41142
Cov.:
37
AF XY:
0.235
AC XY:
170673
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.202
Gnomad4 AMR exome
AF:
0.200
Gnomad4 ASJ exome
AF:
0.288
Gnomad4 EAS exome
AF:
0.131
Gnomad4 SAS exome
AF:
0.200
Gnomad4 FIN exome
AF:
0.206
Gnomad4 NFE exome
AF:
0.243
Gnomad4 OTH exome
AF:
0.232
GnomAD4 genome
AF:
0.227
AC:
34492
AN:
152246
Hom.:
4040
Cov.:
33
AF XY:
0.227
AC XY:
16879
AN XY:
74444
show subpopulations
Gnomad4 AFR
AF:
0.199
Gnomad4 AMR
AF:
0.258
Gnomad4 ASJ
AF:
0.292
Gnomad4 EAS
AF:
0.127
Gnomad4 SAS
AF:
0.199
Gnomad4 FIN
AF:
0.201
Gnomad4 NFE
AF:
0.243
Gnomad4 OTH
AF:
0.246
Alfa
AF:
0.241
Hom.:
8938
Bravo
AF:
0.231
Asia WGS
AF:
0.141
AC:
490
AN:
3478
EpiCase
AF:
0.265
EpiControl
AF:
0.260

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spherocytosis type 1 Benign:5
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabDec 05, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 30, 2023- -
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtOct 10, 2014- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 10, 2018- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Spherocytosis Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
2.1
DANN
Benign
0.60
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs750625; hg19: chr8-41525914; COSMIC: COSV55881841; COSMIC: COSV55881841; API